IL6 and Hyperglycemia: NLRP3/IL-6/IL-1/TNF-α expression was reduced, and diabetes/hyperglycaemia-induced oxidative stress was suppressed, as evidenced by decreased 8-isoprostane and elevated superoxide dismutase-2 levels in vitro and in vivo [159].